Kenneth G. Mertz II
@Emerald Mutual Fund Advisers Trust
Latest period2024 - Q3ReportedManaged Assets$1.925BTotal holdings225
Assets growth rate0.84%Assets growth rate (2-Q avg)0.12%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Emerald Mutual Fund Advisers Trust's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 225 positions.
Assets under management
The assets under management (AUM) of Emerald Mutual Fund Advisers Trust over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.925B in assets, with a quarterly growth rate of 0.84% and a 2-quarter average growth rate of 0.12%. The portfolio is managed by Kenneth G. Mertz II, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
COLLCollegium Pharmaceutical Inc
| 1.33% | $25.591M 662,291 shares@ $38.64 avg price | Increased 24.86% |
TENBTenable Holding
| 1.32% | $25.387M 626,541 shares@ $40.52 avg price | Decreased -5.29% |
LPXLouisiana-pacific Corporation
| 1.29% | $24.785M 230,642 shares@ $107.46 avg price | Increased 0.73% |
MCMoelis & Co
| 1.29% | $24.723M 360,871 shares@ $68.51 avg price | Decreased -5.21% |
ITCIIntra Cellular Therapies
| 1.28% | $24.488M 334,673 shares@ $73.17 avg price | Increased 6.57% |
AIRAar Corporation
| 1.28% | $24.445M 374,012 shares@ $65.36 avg price | Decreased -5.68% |
GTLSChart Inds Inc
| 1.27% | $24.395M 196,514 shares@ $124.15 avg price | Decreased -2.92% |
RAREUltragenyx Pharmaceutical Inc
| 1.24% | $23.848M 429,302 shares@ $55.55 avg price | Increased 9.93% |
MMSIMerit Med Sys Inc
| 1.21% | $23.136M 234,095 shares@ $98.84 avg price | Decreased -23.86% |
PDFSPdf Solutions Inc
| 1.2% | $23.068M 728,144 shares@ $31.69 avg price | Increased 1.71% |